Antimicrobial Resistance in Urinary Tract Infections: Current Scenario, Mechanisms, and Challenges in India - A Narrative Review
International Journal of Drug Delivery Technology · 20.06.2026 · 16 (59s)
DOI: 10.25258/ijddt.16.59s.82 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 20.06.2026. Verfasst von Aniket Aniket.
Abstract (Originalsprache)
Background
Antimicrobial resistance (AMR) has emerged as a major health problem worldwide with low- and middleincome countries being especially vulnerable, with India being no exception. One of the most frequent bacterial infections is Urinary tract infections (UTIs) and are a significant contributor to antibiotic use and consequently resistance.
Purpose
This narrative review is a synthesis of literature on the epidemiology, the resistant patterns, molecular pathophysiology and clinical issues related to antimicrobial resistance of uropathogens in India.
Methods
A narrative review methodology was employed, which comprised evidence from 55 peer-reviewed studies covering the period 2010-2025, including national and international surveillance reports. Studies covering UTIs, antimicrobial susceptibility and resistance mechanisms in India and the world were included.
Results
The most prevalent uropathogen identified in the review is Escherichia coli and Klebsiella pneumoniae, which exhibit high resistance to commonly used antibiotics, such as fluoroquinolones, cephalosporins, and ampicillin. There has been an increasing trend in the number of NDM-1-producing organisms as well as extended-spectrum β-lactamase (ESBL) and carbapenemase-producing organisms in both community and hospital settings. Nitrofurantoin and fosfomycin remain moderately effective options, while carbapenems are increasingly reserved as treatments of last resort. The main causes of AMR in India are the misuse of antibiotics, low quality of healthcare facilities, socioeconomic inequalities, and environmental conditions. Diagnostic, treatment and surveillance systems continue to pose significant challenges.
Conclusion
AMR in Urinary tract infections (UTIs) in India is rapidly soaring, and multidrug-resistant Gram-negative uropathogens, as well as systemic healthcare inadequacies, are present. The key to reducing this increasing threat is to strengthen antimicrobial stewardship, improve surveillance networks, increase diagnostic capacity, and a One Health approach
Zitieren
APA
Aniket, A. (2026). Antimicrobial Resistance in Urinary Tract Infections: Current Scenario, Mechanisms, and Challenges in India - A Narrative Review. International Journal of Drug Delivery Technology, 16(59s). https://doi.org/10.25258/ijddt.16.59s.82
Vancouver
Aniket A. Antimicrobial Resistance in Urinary Tract Infections: Current Scenario, Mechanisms, and Challenges in India - A Narrative Review. International Journal of Drug Delivery Technology. 2026;16(59s). doi:10.25258/ijddt.16.59s.82
BibTeX
@article{Aniket2026,
author = {Aniket, Aniket},
title = {Antimicrobial Resistance in Urinary Tract Infections: Current Scenario, Mechanisms, and Challenges in India - A Narrative Review},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {59s},
doi = {10.25258/ijddt.16.59s.82}
}
EUVIMED